TECLens
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9 Riverbend Dr S Ste C, Stamford, Connec...Phone Number
(631) 751-8670Website
www.teclens.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About TECLens
Based in Stamford, CT, TECLens is a clinical-stage medical device company developing an innovative, non-invasive cornea cross-linking procedure to treat keratoconus, low order myopia and eventually presbyopia. TECLens' proprietary 'on-eye' CXL technology consists of a single-use disposable contact lens (CXLens®) and a small control system. The system can treat both eyes simultaneously for keratoconus, and provides integrated real-time ultrasound feedback and patterned ultraviolet light delivery for refractive indications. TECLens believes on-eye cross-linking will become a safe, simple, and permanent alternative to LASIK, contact lenses, and eyeglasses for millions of people with vision errors.Explore more
TECLens Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TECLens your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once TECLens has new funding data
Check out if TECLens is spiking on competitors!
TECLens, which may be a good buyer, showed buying intent in Masked Content Topic
Check if TECLens has recently received funding, and reach out quickly before it becomes old news!
Click to see if TECLens had a recent Job posting/layoffs
Earning: See what the market has to say on TECLens recently announced quarterly report
Product Launch: Get notified when TECLens launches new products
Congratulate Masked Content for being promoted to Masked Content at TECLens
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined TECLens as Masked Content
Find more new buyers
Compare Similar Companies to TECLens
Compare insights from companies similar to TECLens, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TECLens is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TECLens is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TECLens.
TECLens financials insights
Gather financial insights about TECLens, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$1.2M
2025
Series A
$9.3M
TECLens Tech Stack
A closer look at the technologies used by TECLens
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Funding
Funding
Person-Based
TECLens News & Media
TECLens Secures $9.3 Million Series A Funding - Medical Product Outsourcing
Ophthalmic medical device firm TECLens raises $9.3 million in a Series A funding round led by Johnson & Johnson Innovation.TECLens Secures $9.3 Million Series A Funding to Advance Its Non-Invasive Refractive Technology
STAMFORD, Conn.--(BUSINESS WIRE)--TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation – JJDC Inc. and Yonjin Capital. Other investors include Rimonci Capital, and Sunmed Capital. The funding is allocated to support the clinical development of the company’s non-incisional refractive correction procedure that leverages corneal cross-linking (CXL) to reshape the cornea. “We're increTECLens Announces Completion of Enrollment of a Pilot Clinical Study for the Treatment of Keratoconus
STAMFORD, Conn., Oct. 10, 2019 /PRNewswire/ -- TECLens, a medical device manufacturer, today announced the completion of enrollment of its pilot clinical study for the treatment of Keratoconus using the TECLens' CXLens® 'on-eye' cross-linking system for corneal remodeling. Clinical trial...TECLens and SERVImed Industrial Spa Announce a Partnership to Pursue U.S. FDA Approval for Trans-epithelial Corneal Cross-Linking
STAMFORD, Conn., Oct. 7, 2019 /PRNewswire/ -- TECLens, a medical device manufacturer and SERVImed Industrial Spa, an ophthalmic medical devices manufacturer and distributor today announced their partnership aimed at development and FDA approval of a new combination product to treat...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TECLens
Sign Up For FreeTo access detailed company insights
Based in Stamford, CT, TECLens is a clinical-stage medical device company developing an innovative, non-invasive cornea cross-linking procedure to treat keratoconus, low order myopia and eventually presbyopia. TECLens' proprietary 'on-eye' CXL technology consists of a single-use disposable contact lens (CXLens®) and a small control system. The syst... Read More
